Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
The percent change in body weight and in sitting diastolic blood pressure from baseline/randomization (Week 0) to Week 60.
Percent change in body weight (from enrollment only), absolute change in body weight, Body Mass Index, sitting systolic and diastolic blood pressure from enrollment and baseline to week 60; safety evaluations during the study.
18 Years to 75 Years (Adult, Senior)
October 12, 2005
April 28, 2010
† Study has passed its completion date and status has not been verified in more than two years.